 | • レポートコード：B-GIR09D4248 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、組換え血漿タンパク質の世界市場について調べ、まとめました。種類別セグメントは、チャイニーズハムスター卵巣（CHO）細胞株、ベビーハムスター腎臓（BHK）細胞株、ヒト胚性腎臓（HEK）細胞株、その他等、用途別セグメントは、血友病A、血友病B、フォンウィルブランド病、その他等に区分しました。組換え血漿タンパク質の世界市場概観、企業動向、企業別組換え血漿タンパク質シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・組換え血漿タンパク質の市場概観 ・組換え血漿タンパク質の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・組換え血漿タンパク質の企業別販売動向、市場シェア、市場集中度、競争動向 ・組換え血漿タンパク質の世界市場規模 ・組換え血漿タンパク質の北米市場分析（アメリカ、カナダ、メキシコ等） ・組換え血漿タンパク質のアメリカ市場規模推移 ・組換え血漿タンパク質のカナダ市場規模推移 ・組換え血漿タンパク質のメキシコ市場規模推移 ・組換え血漿タンパク質のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・組換え血漿タンパク質のドイツ市場規模推移 ・組換え血漿タンパク質のイギリス市場規模推移 ・組換え血漿タンパク質のロシア市場規模推移 ・組換え血漿タンパク質のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・組換え血漿タンパク質の日本市場規模推移 ・組換え血漿タンパク質の中国市場規模推移 ・組換え血漿タンパク質の韓国市場規模推移 ・組換え血漿タンパク質のインド市場規模推移 ・組換え血漿タンパク質の東南アジア市場規模推移 ・組換え血漿タンパク質の南米市場分析（ブラジル、アルゼンチン等） ・組換え血漿タンパク質の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・組換え血漿タンパク質の種類別分析/販売量、売上、市場シェア（チャイニーズハムスター卵巣（CHO）細胞株、ベビーハムスター腎臓（BHK）細胞株、ヒト胚性腎臓（HEK）細胞株、その他） ・組換え血漿タンパク質の用途別分析/市場規模（血友病A、血友病B、フォンウィルブランド病、その他） ・組換え血漿タンパク質の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・組換え血漿タンパク質の販売チャネル・代理店・貿易業者・ディーラー分析 |
For almost 50 years, the fractionation of human plasma has been the sole possible source of a wide range of therapeutic proteins–such as coagulation factors, anticoagulants, immunoglobulins, and albumin–essential to the treatment of serious congenital or acquired bleeding or immunological diseases. In the last 20 years, the application of recombinant technologies to mammalian cell cultures has made possible–although with some limitations in productivity, costs, and immunogenic risks-
Scope of the Report:
The global Recombinant Plasma Proteins market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Recombinant Plasma Proteins.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Recombinant Plasma Proteins market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Recombinant Plasma Proteins market by product type and applications/end industries.
Market Segment by Companies, this report covers
CSL Limited
Shire (Takeda Pharmaceutical Company Limited)
Octapharma
Novo Nordisk
Bayer
Bioverativ Therapeutics, Inc. (Sanofi)
Aptevo Therapeutics
Pharming Group
Pfizer
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Chinese Hamster Ovary (CHO) Cell Line
Baby Hamster Kidney (BHK) Cell Line
Human Embryonic Kidney (HEK) Cell Line
Others
Market Segment by Applications, can be divided into
Hemophilia A
Hemophilia B
Von Willebrand Disease
Others
Table of Contents
1 Recombinant Plasma Proteins Market Overview
1.1 Product Overview and Scope of Recombinant Plasma Proteins
1.2 Classification of Recombinant Plasma Proteins by Types
1.2.1 Global Recombinant Plasma Proteins Revenue Comparison by Types (2019-2024)
1.2.2 Global Recombinant Plasma Proteins Revenue Market Share by Types in 2018
1.2.3 Chinese Hamster Ovary (CHO) Cell Line
1.2.4 Baby Hamster Kidney (BHK) Cell Line
1.2.5 Human Embryonic Kidney (HEK) Cell Line
1.2.6 Others
1.3 Global Recombinant Plasma Proteins Market by Application
1.3.1 Global Recombinant Plasma Proteins Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hemophilia A
1.3.3 Hemophilia B
1.3.4 Von Willebrand Disease
1.3.5 Others
1.4 Global Recombinant Plasma Proteins Market by Regions
1.4.1 Global Recombinant Plasma Proteins Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Recombinant Plasma Proteins Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Recombinant Plasma Proteins Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Recombinant Plasma Proteins Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Recombinant Plasma Proteins Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Recombinant Plasma Proteins Status and Prospect (2014-2024)
1.5 Global Market Size of Recombinant Plasma Proteins (2014-2024)
2 Manufacturers Profiles
2.1 CSL Limited
2.1.1 Business Overview
2.1.2 Recombinant Plasma Proteins Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 CSL Limited Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2017-2018)
2.2 Shire (Takeda Pharmaceutical Company Limited)
2.2.1 Business Overview
2.2.2 Recombinant Plasma Proteins Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Shire (Takeda Pharmaceutical Company Limited) Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2017-2018)
2.3 Octapharma
2.3.1 Business Overview
2.3.2 Recombinant Plasma Proteins Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Octapharma Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2017-2018)
2.4 Novo Nordisk
2.4.1 Business Overview
2.4.2 Recombinant Plasma Proteins Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novo Nordisk Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2017-2018)
2.5 Bayer
2.5.1 Business Overview
2.5.2 Recombinant Plasma Proteins Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bayer Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2017-2018)
2.6 Bioverativ Therapeutics, Inc. (Sanofi)
2.6.1 Business Overview
2.6.2 Recombinant Plasma Proteins Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bioverativ Therapeutics, Inc. (Sanofi) Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2017-2018)
2.7 Aptevo Therapeutics
2.7.1 Business Overview
2.7.2 Recombinant Plasma Proteins Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Aptevo Therapeutics Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2017-2018)
2.8 Pharming Group
2.8.1 Business Overview
2.8.2 Recombinant Plasma Proteins Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Pharming Group Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2017-2018)
2.9 Pfizer
2.9.1 Business Overview
2.9.2 Recombinant Plasma Proteins Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pfizer Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2017-2018)
3 Global Recombinant Plasma Proteins Market Competition, by Players
3.1 Global Recombinant Plasma Proteins Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Recombinant Plasma Proteins Players Market Share
3.2.2 Top 10 Recombinant Plasma Proteins Players Market Share
3.3 Market Competition Trend
4 Global Recombinant Plasma Proteins Market Size by Regions
4.1 Global Recombinant Plasma Proteins Revenue and Market Share by Regions
4.2 North America Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
4.3 Europe Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
4.5 South America Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
5 North America Recombinant Plasma Proteins Revenue by Countries
5.1 North America Recombinant Plasma Proteins Revenue by Countries (2014-2019)
5.2 USA Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
5.3 Canada Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
5.4 Mexico Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
6 Europe Recombinant Plasma Proteins Revenue by Countries
6.1 Europe Recombinant Plasma Proteins Revenue by Countries (2014-2019)
6.2 Germany Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
6.3 UK Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
6.4 France Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
6.5 Russia Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
6.6 Italy Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Recombinant Plasma Proteins Revenue by Countries
7.1 Asia-Pacific Recombinant Plasma Proteins Revenue by Countries (2014-2019)
7.2 China Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
7.3 Japan Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
7.4 Korea Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
7.5 India Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
8 South America Recombinant Plasma Proteins Revenue by Countries
8.1 South America Recombinant Plasma Proteins Revenue by Countries (2014-2019)
8.2 Brazil Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
8.3 Argentina Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
8.4 Colombia Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Recombinant Plasma Proteins by Countries
9.1 Middle East and Africa Recombinant Plasma Proteins Revenue by Countries (2014-2019)
9.2 Saudi Arabia Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
9.3 UAE Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
9.4 Egypt Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
9.5 Nigeria Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
9.6 South Africa Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
10 Global Recombinant Plasma Proteins Market Segment by Type
10.1 Global Recombinant Plasma Proteins Revenue and Market Share by Type (2014-2019)
10.2 Global Recombinant Plasma Proteins Market Forecast by Type (2019-2024)
10.3 Chinese Hamster Ovary (CHO) Cell Line Revenue Growth Rate (2014-2024)
10.4 Baby Hamster Kidney (BHK) Cell Line Revenue Growth Rate (2014-2024)
10.5 Human Embryonic Kidney (HEK) Cell Line Revenue Growth Rate (2014-2024)
10.6 Others Revenue Growth Rate (2014-2024)
11 Global Recombinant Plasma Proteins Market Segment by Application
11.1 Global Recombinant Plasma Proteins Revenue Market Share by Application (2014-2019)
11.2 Recombinant Plasma Proteins Market Forecast by Application (2019-2024)
11.3 Hemophilia A Revenue Growth (2014-2019)
11.4 Hemophilia B Revenue Growth (2014-2019)
11.5 Von Willebrand Disease Revenue Growth (2014-2019)
11.6 Others Revenue Growth (2014-2019)
12 Global Recombinant Plasma Proteins Market Size Forecast (2019-2024)
12.1 Global Recombinant Plasma Proteins Market Size Forecast (2019-2024)
12.2 Global Recombinant Plasma Proteins Market Forecast by Regions (2019-2024)
12.3 North America Recombinant Plasma Proteins Revenue Market Forecast (2019-2024)
12.4 Europe Recombinant Plasma Proteins Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Recombinant Plasma Proteins Revenue Market Forecast (2019-2024)
12.6 South America Recombinant Plasma Proteins Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Recombinant Plasma Proteins Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Recombinant Plasma Proteins Picture
Table Product Specifications of Recombinant Plasma Proteins
Table Global Recombinant Plasma Proteins and Revenue (Million USD) Market Split by Product Type
Figure Global Recombinant Plasma Proteins Revenue Market Share by Types in 2018
Figure Chinese Hamster Ovary (CHO) Cell Line Picture
Figure Baby Hamster Kidney (BHK) Cell Line Picture
Figure Human Embryonic Kidney (HEK) Cell Line Picture
Figure Others Picture
Table Global Recombinant Plasma Proteins Revenue (Million USD) by Application (2014-2024)
Figure Recombinant Plasma Proteins Revenue Market Share by Applications in 2018
Figure Hemophilia A Picture
Figure Hemophilia B Picture
Figure Von Willebrand Disease Picture
Figure Others Picture
Table Global Market Recombinant Plasma Proteins Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Recombinant Plasma Proteins Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Recombinant Plasma Proteins Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Recombinant Plasma Proteins Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Recombinant Plasma Proteins Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Recombinant Plasma Proteins Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Recombinant Plasma Proteins Revenue (Million USD) and Growth Rate (2014-2024)
Table CSL Limited Basic Information, Manufacturing Base and Competitors
Table CSL Limited Recombinant Plasma Proteins Type and Applications
Table CSL Limited Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2017-2018)
Table Shire (Takeda Pharmaceutical Company Limited) Basic Information, Manufacturing Base and Competitors
Table Shire (Takeda Pharmaceutical Company Limited) Recombinant Plasma Proteins Type and Applications
Table Shire (Takeda Pharmaceutical Company Limited) Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2017-2018)
Table Octapharma Basic Information, Manufacturing Base and Competitors
Table Octapharma Recombinant Plasma Proteins Type and Applications
Table Octapharma Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2017-2018)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Recombinant Plasma Proteins Type and Applications
Table Novo Nordisk Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Recombinant Plasma Proteins Type and Applications
Table Bayer Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2017-2018)
Table Bioverativ Therapeutics, Inc. (Sanofi) Basic Information, Manufacturing Base and Competitors
Table Bioverativ Therapeutics, Inc. (Sanofi) Recombinant Plasma Proteins Type and Applications
Table Bioverativ Therapeutics, Inc. (Sanofi) Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2017-2018)
Table Aptevo Therapeutics Basic Information, Manufacturing Base and Competitors
Table Aptevo Therapeutics Recombinant Plasma Proteins Type and Applications
Table Aptevo Therapeutics Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2017-2018)
Table Pharming Group Basic Information, Manufacturing Base and Competitors
Table Pharming Group Recombinant Plasma Proteins Type and Applications
Table Pharming Group Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Recombinant Plasma Proteins Type and Applications
Table Pfizer Recombinant Plasma Proteins Revenue, Gross Margin and Market Share (2017-2018)
Table Global Recombinant Plasma Proteins Revenue (Million USD) by Players (2014-2019)
Table Global Recombinant Plasma Proteins Revenue Share by Players (2014-2019)
Figure Global Recombinant Plasma Proteins Revenue Share by Players in 2017
Figure Global Recombinant Plasma Proteins Revenue Share by Players in 2018
Figure Global Top 5 Players Recombinant Plasma Proteins Revenue Market Share in 2018
Figure Global Top 10 Players Recombinant Plasma Proteins Revenue Market Share in 2018
Figure Global Recombinant Plasma Proteins Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Recombinant Plasma Proteins Revenue (Million USD) by Regions (2014-2019)
Table Global Recombinant Plasma Proteins Revenue Market Share by Regions (2014-2019)
Figure Global Recombinant Plasma Proteins Revenue Market Share by Regions (2014-2019)
Figure Global Recombinant Plasma Proteins Revenue Market Share by Regions in 2018
Figure North America Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Figure Europe Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Figure South America Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Table North America Recombinant Plasma Proteins Revenue by Countries (2014-2019)
Table North America Recombinant Plasma Proteins Revenue Market Share by Countries (2014-2019)
Figure North America Recombinant Plasma Proteins Revenue Market Share by Countries (2014-2019)
Figure North America Recombinant Plasma Proteins Revenue Market Share by Countries in 2018
Figure USA Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Figure Canada Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Figure Mexico Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Table Europe Recombinant Plasma Proteins Revenue (Million USD) by Countries (2014-2019)
Figure Europe Recombinant Plasma Proteins Revenue Market Share by Countries (2014-2019)
Figure Europe Recombinant Plasma Proteins Revenue Market Share by Countries in 2018
Figure Germany Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Figure UK Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Figure France Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Figure Russia Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Figure Italy Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Recombinant Plasma Proteins Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Recombinant Plasma Proteins Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Recombinant Plasma Proteins Revenue Market Share by Countries in 2018
Figure China Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Figure Japan Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Figure Korea Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Figure India Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Table South America Recombinant Plasma Proteins Revenue by Countries (2014-2019)
Table South America Recombinant Plasma Proteins Revenue Market Share by Countries (2014-2019)
Figure South America Recombinant Plasma Proteins Revenue Market Share by Countries (2014-2019)
Figure South America Recombinant Plasma Proteins Revenue Market Share by Countries in 2018
Figure Brazil Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Figure Argentina Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Figure Colombia Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Recombinant Plasma Proteins Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Recombinant Plasma Proteins Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Recombinant Plasma Proteins Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Recombinant Plasma Proteins Revenue Market Share by Countries in 2018
Figure Saudi Arabia Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Figure UAE Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Figure Egypt Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Figure Nigeria Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Figure South Africa Recombinant Plasma Proteins Revenue and Growth Rate (2014-2019)
Table Global Recombinant Plasma Proteins Revenue (Million USD) by Type (2014-2019)
Table Global Recombinant Plasma Proteins Revenue Share by Type (2014-2019)
Figure Global Recombinant Plasma Proteins Revenue Share by Type (2014-2019)
Figure Global Recombinant Plasma Proteins Revenue Share by Type in 2019
Table Global Recombinant Plasma Proteins Revenue Forecast by Type (2019-2024)
Figure Global Recombinant Plasma Proteins Market Share Forecast by Type (2019-2024)
Figure Global Chinese Hamster Ovary (CHO) Cell Line Revenue Growth Rate (2014-2019)
Figure Global Baby Hamster Kidney (BHK) Cell Line Revenue Growth Rate (2014-2019)
Figure Global Human Embryonic Kidney (HEK) Cell Line Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Recombinant Plasma Proteins Revenue by Application (2014-2019)
Table Global Recombinant Plasma Proteins Revenue Share by Application (2014-2019)
Figure Global Recombinant Plasma Proteins Revenue Share by Application (2014-2019)
Figure Global Recombinant Plasma Proteins Revenue Share by Application in 2019
Table Global Recombinant Plasma Proteins Revenue Forecast by Application (2019-2024)
Figure Global Recombinant Plasma Proteins Market Share Forecast by Application (2019-2024)
Figure Global Hemophilia A Revenue Growth Rate (2014-2019)
Figure Global Hemophilia B Revenue Growth Rate (2014-2019)
Figure Global Von Willebrand Disease Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Recombinant Plasma Proteins Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Recombinant Plasma Proteins Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Recombinant Plasma Proteins Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Recombinant Plasma Proteins Revenue Market Forecast (2019-2024)
Figure Europe Recombinant Plasma Proteins Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Recombinant Plasma Proteins Revenue Market Forecast (2019-2024)
Figure South America Recombinant Plasma Proteins Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Recombinant Plasma Proteins Revenue Market Forecast (2019-2024)
世界の組換え血漿タンパク質治療薬市場予測（～2024年） The global recombinant plasma protein therapeutics market is driven by various factors such as shift from use of plasma-derived proteins to recombinant therapies, rise in awareness about rare disease management and increased focus on investments in rare diseases. Additionally, steady increase in the…- 世界の組換え細胞培養サプリメント市場予測（～2024年） Recombinant proteins are increasingly being used as defined supplements in biopharmaceutical, vaccine and stem cell manufacturing. Scope of the Report: The global Recombinant Cell Culture Supplements market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 202…
- 世界の血漿分画市場予測（～2024年） Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation. Scope of the Report: Plasma Fractionation is widely used f…
- 世界の血漿タンパク質システム市場予測（～2024年） Plasma protein system is a unique and biologic pathway that are either injected or infused to treat a life-threatening chronic and generic disease including pulmonary disorder, neurologic disorder, bleeding disorder, immune deficiencies, liver cirrhosis, trauma and others. Scope of the Report: The g…
- 世界の血漿タンパク質製品市場予測（～2024年） Plasma is used as a raw material to produce a category of drugs called plasma protein products. Scope of the Report: The worldwide market for Plasma Protein Products is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019,…